Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
MousePhenoabnormal mitotic spindle morphology

NUSAP1 CEP57

1.79e-043682MP:0009760
MousePhenodecreased circulating amylase level

NRGN MYBPC3

1.89e-043782MP:0008805
DomainHelicase_C

ERCC3 DDX31

1.14e-0310792PF00271
DomainHELICc

ERCC3 DDX31

1.14e-0310792SM00490
DomainHelicase_C

ERCC3 DDX31

1.16e-0310892IPR001650
DomainDEXDc

ERCC3 DDX31

1.18e-0310992SM00487
DomainHELICASE_CTER

ERCC3 DDX31

1.18e-0310992PS51194
DomainHELICASE_ATP_BIND_1

ERCC3 DDX31

1.18e-0310992PS51192
DomainHelicase_ATP-bd

ERCC3 DDX31

1.20e-0311092IPR014001
Pubmed

ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2.

ERCC3 TNRC6A

4.16e-05389230629181
Pubmed

Transcription factor Foxp3 and its protein partners form a complex regulatory network.

NUSAP1 NOL12 ERCC3

9.57e-053709322922362
Pubmed

The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.

NUSAP1 NOL12 DDX31

2.10e-044839336912080
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

NUSAP1 ERCC3 DDX31 TNRC6A

2.58e-0413719436244648
ToppCelldroplet-Fat-Scat-18m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NUSAP1 PRSS35

1.14e-04819240981efef1b79adaa08fd20cf87955d0ae973ca7
ToppCelldroplet-Fat-Scat-18m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NUSAP1 PRSS35

1.14e-0481929a1cc6da6b7e697159a857c0dfe6e2a494160f9c
ToppCelldroplet-Fat-Scat-18m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NUSAP1 PRSS35

1.14e-04819298ee7f5a66dc29c9563cabea8160f118bcbbde73
ToppCellHippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3|Hippocampus / BrainAtlas - Mouse McCarroll V32

PRSS35 MYBPC3

2.81e-04127929bc55cb9f4bddb274930784d12a83b9dceb35cb7
ToppCellHippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3-Excitatory_Neuron.Slc17a7.Pvrl3-Nos1_(CA3_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32

PRSS35 MYBPC3

2.85e-04128929128b633879d21de2ebe651384cfec6d2c3c2932
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

CEP57 DDX31

3.51e-0414292199a0a1024b6cc446f5ca1f277846a2bdb227a9f
ToppCellHippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32

PRSS35 NRGN

3.76e-04147928f725ff8fb4ced5db2643e80669d3f7945b820ab
ToppCellPND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NUSAP1 NRGN

4.18e-04155928e239470799426ea474a36f57e1b7e0d9365ca5f
ToppCell343B-Lymphocytic-NK_cells-NK_cell_E|343B / Donor, Lineage, Cell class and subclass (all cells)

ERCC3 DDX31

4.29e-04157920362c04b7b0b5017964b3a73ee678ae53e7238d7
ToppCelldroplet-Lung-nan-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NUSAP1 NRGN

4.34e-0415892ee8ce3cd202807df692b28bb1a81827d49d73862
ToppCellControl-Hematopoietic_Meg-Ery-Platelets-Platelets|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NUSAP1 NRGN

4.34e-0415892f2c39b2eff8f2728a9d482d88e0d04984306a3fd
ToppCellControl-Hematopoietic_Meg-Ery-Platelets|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NUSAP1 NRGN

4.34e-0415892fa9797a23254070c569fabe8a314b3e8b3ae9ebd
ToppCellPND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NUSAP1 CEP57

4.40e-0415992e9c51e611ebd427bbe51e3e036c14122c36ea372
ToppCell390C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

NRGN CEP57

4.40e-0415992af137688e06a97ff97bb7def54f0dd164d155b11
ToppCell3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue

NUSAP1 NRGN

4.62e-041639247300dec94dc66e965bf71fafff0a9fd24fae968
ToppCellPND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NUSAP1 NRGN

4.68e-04164925621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c
ToppCellLPS-antiTNF-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NUSAP1 PRSS35

4.73e-041659215fd9d21dccfa80656a6fa3b72286a6a9252d403
ToppCell10x5'-Lung-Hematopoietic_progenitors|Lung / Manually curated celltypes from each tissue

NUSAP1 NRGN

4.85e-0416792dec18caf0475002d4ad3c7bc7fc3050cbc8e6bae
ToppCell10x5'-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue

NUSAP1 NRGN

4.85e-041679282739226347d74897be000f429b73543a031af96
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PRSS35 MYBPC3

4.96e-0416992a6a5b00912b653fad2ca7f096deaf35c9ef85e5b
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PRSS35 MYBPC3

4.96e-041699242a9b8c77d2a4d68b01e4db38f8a1af53c9c814f
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PRSS35 MYBPC3

4.96e-041699288aa2246ede582c2e11de63228d76f520889ecb3
ToppCellInfluenza_Severe-gd_T|Influenza_Severe / Disease group and Cell class

PRSS35 NOL12

5.02e-041709259009c5a504ea8c6b4f6697299db219fd5edf7d6
ToppCellPND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NUSAP1 NRGN

5.08e-0417192846a9acfff0bf0a9baf65dc07b7d7a9217ed6598
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRSS35 NRGN

5.14e-0417292107417cfab7775bc1f80807115047abfb50b7a7e
ToppCell343B-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

ERCC3 DDX31

5.26e-0417492a1f745962a104c6f4b86b7e482da8755384c773a
ToppCellfacs-Lung-EPCAM-3m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRGN DDX31

5.26e-04174927f8f6a15a823809effd37c1a5b09ef19b6d67755
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue

NUSAP1 NRGN

5.26e-0417492e4c8da80eca07e4396f57dad212f76c2eca4c1bd
ToppCellfacs-Lung-EPCAM-3m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRGN DDX31

5.26e-0417492a8bd1fa08bf061a627529a38e5a23a68b6d80697
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NUSAP1 PRSS35

5.26e-04174927b2f35add804981c7d588a996bdbca6ec11a1ca5
ToppCell343B-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

ERCC3 DDX31

5.32e-041759278a86cac3e6c0d115c997d1c29ee0e24af54551f
ToppCellwk_20-22-Hematologic-Myeloid-Promonocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

NUSAP1 NRGN

5.32e-0417592654299df246debe0a5b12f0d9568eb828bb94bb9
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PRSS35 MYBPC3

5.38e-04176924ed73c73972334f6dc4229920205547823252fa0
ToppCellMonocytes-IFN-activated_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

NUSAP1 NRGN

5.38e-04176926a4b403ee3e4dc4f23fbd7a154011e41fd429a9e
ToppCell343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|343B / Donor, Lineage, Cell class and subclass (all cells)

NUSAP1 NOL12

5.50e-04178925289ac61637224ae70ffbc2d164d73116f10af40
ToppCell343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

NUSAP1 NRGN

5.50e-0417892c7e890cd02206c516cf1d7692ea7abc8ce746482
ToppCelldroplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRGN DDX31

5.56e-0417992025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue

NUSAP1 NRGN

5.69e-0418192ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRSS35 MYBPC3

5.75e-0418292c4a7007c864a9455a7e7447e28ccd380878a6a0f
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NUSAP1 DDX31

5.75e-0418292d1c3cc2942faec7527a3c25869fd65c17899e5e4
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NUSAP1 DDX31

5.75e-041829292f83f29e358000cd86a709eb8b6199761ffe8bd
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRSS35 MYBPC3

5.75e-0418292c315d820ffad912c014ba5eac6f5fa6de1a94384
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NUSAP1 DDX31

5.75e-041829202baca9a72c7b559c3e452693b3b134af804c868
ToppCell10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|bone_marrow / Manually curated celltypes from each tissue

NUSAP1 NRGN

6.00e-0418692e82d5e7a976b9cfa2b4640c7a7cd1cfea19c4806
ToppCell5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRSS35 NRGN

6.00e-04186921e3ab663e4756975db6d802b2c6c054a94a79393
ToppCell3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRSS35 NRGN

6.00e-04186920b2ce9b8a4382d583240647217ad5e2d3fa555c1
ToppCell356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|356C / Donor, Lineage, Cell class and subclass (all cells)

NUSAP1 NRGN

6.00e-0418692189b75aa98903f1cb65b624524ba6c30df7e42ff
ToppCell356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|356C / Donor, Lineage, Cell class and subclass (all cells)

NUSAP1 NRGN

6.00e-0418692261891d0b148e285339ae0b9e36136ceabd9b6f5
ToppCell5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRSS35 NRGN

6.07e-0418792b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f
ToppCell3'_v3-GI_small-bowel-Lymphocytic_NK-Cycling_NK|GI_small-bowel / Manually curated celltypes from each tissue

NUSAP1 NRGN

6.07e-0418792265c690c2921fd201361a0ec8bc4d2a996fbcaf4
ToppCell3'_v3-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue

NRGN MYBPC3

6.07e-0418792c20689022569640ebc4a878e3fe146b86fe9b386
ToppCell15-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class

PRSS35 NRGN

6.13e-04188924963382e54aac06bf5047c7d725393db70667ee7
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NUSAP1 PRSS35

6.13e-041889295d0a796d62ce6d121e2028c378faffc14b35275
ToppCell11.5-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class

PRSS35 NRGN

6.13e-0418892916971d8660fd20f616346953874e89d2cd13e88
ToppCellSevere-MAIT|World / Disease group and Cell class

PRSS35 MYBPC3

6.26e-04190927a92e0d6a021be23125495927b8571e25c83204a
ToppCellSevere-MAIT|Severe / Disease group and Cell class

PRSS35 MYBPC3

6.26e-04190921c063dc1b62d9f9912aaf8d0297555a6545f5550
ToppCell3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue

NUSAP1 NRGN

6.33e-0419192e642fa7395c05fb53324c9d46bbc52f89fc9673f
ToppCell5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NUSAP1 NRGN

6.46e-0419392dd443b83d328a9069ffe19ac3d74066e922515a5
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NUSAP1 NRGN

6.46e-0419392ecbe1bd16df547427da5e69a3017300e766c2899
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NUSAP1 PRSS35

6.46e-0419392a332dfdcc48c405020014e644aa4d14fda98cc86
ToppCellSevere_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）

NUSAP1 NRGN

6.46e-04193920d85025690c9cd545cba30abc38acbdd6a39b153
ToppCellBAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

NUSAP1 NRGN

6.53e-0419492903ae11708b0cb24538c6982abd57fe6fa95b8d3
ToppCell(3)_Chondrocytes-(33)_Chondro-prol/rest|World / Cell class and subclass of bone marrow stroma cells in homeostatis

NUSAP1 NRGN

6.53e-0419492c093c5e161b97ad770bfbaad3023eba4537101b5
ToppCell(3)_Chondrocytes-(33)_Chondro-prol/rest|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis

NUSAP1 NRGN

6.53e-04194924a207630d72059345b10010f5cfd3b1462458324
ToppCellBAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NUSAP1 NRGN

6.53e-0419492cb39850e9577015b6b9834e98c36b412bae7d462
ToppCellBAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NUSAP1 NRGN

6.53e-0419492408597c9aa302a44b112c1d612c21fbb0227a82a
ToppCellBAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

NUSAP1 NRGN

6.53e-0419492193cc20fefbd795a4ad59e401a95af47d30603e7
ToppCellBAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NUSAP1 NRGN

6.53e-04194922360b5f995b360419de41612368cab9fb61781a1
ToppCellBAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

NUSAP1 NRGN

6.53e-041949258406502a8cbcc3037f79a1b6a683df408297ae5
ToppCell(7)_Epithelial-J_(AT1-AT2_progenitors)|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

NUSAP1 NRGN

6.59e-041959270e6b58c502a2abeb4e36bed179020c675468bd4
ToppCellNon-neuronal-Dividing-Radial_Glia-late-42|World / Primary Cells by Cluster

NUSAP1 PRSS35

6.73e-04197920057aa4bce8684711b061710eab1d2b85e14e055
ToppCellNon-neuronal-Dividing-Radial_Glia-late|World / Primary Cells by Cluster

NUSAP1 PRSS35

6.73e-04197929a65a54e097947601d8e382c4f4b4f5c2c1df51c
ToppCell3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue

NUSAP1 NRGN

6.80e-04198925c92687b853ebb00960adbef6552f9d460bc6886
ToppCellCaecum-T_cell-cycling_gd_T|Caecum / Region, Cell class and subclass

NUSAP1 NRGN

6.80e-04198925b719b67f8384863077070e1eb7e04a320e6dab4
ToppCellCaecum-(1)_T_cell-(18)_cycling_gd_T|Caecum / shred on region, Cell_type, and subtype

NUSAP1 NRGN

6.80e-041989264278d8831c81874937e76b561c53928dfc437c5
ToppCellCaecum-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass

NUSAP1 NRGN

6.80e-0419892d2def132f3efe9305a5501a96ec82efb1f02c3f7
ToppCell10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

NUSAP1 NRGN

6.80e-04198922e669da80363163b806f23a645474d482797ae5d
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating-AT2_proliferating_L.0.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NUSAP1 NRGN

6.87e-0419992d7dbc551c05da32c698908348572fb0ce1166e10
ToppCellCaecum-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass

NUSAP1 NRGN

6.87e-041999264d1e495307a91bc012130613126d86e0cf170b0
ToppCellTCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9

NUSAP1 DDX31

6.87e-041999238f1f612b29feb868322999ceeda78e52447ec4f
ToppCellControl_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|Control_saline / Treatment groups by lineage, cell group, cell type

NUSAP1 NRGN

6.87e-041999286d4e5dd3bcc6bafa48fd0211dad39a2456b53be
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NUSAP1 NRGN

6.87e-04199926a89c3a65fa50af92585c52bec203bcff6f94efc
ToppCell3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|bone_marrow / Manually curated celltypes from each tissue

NUSAP1 NRGN

6.87e-0419992961666a677589c65f733f7262822689101d39ae3
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9

NUSAP1 DDX31

6.87e-0419992b10698aee2e6c17bc559eb4f723024141f914b90
ToppCell343B-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells)

NUSAP1 CEP57

6.93e-04200925f2fbd789cc16af411a01c3199583888b260ae91
ToppCell356C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells)

NUSAP1 NRGN

6.93e-0420092548a0f486ab8745da107f2815914dbf873a6e3c8
Druggeldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A

NRGN ERCC3 DDX31

4.85e-05193936946_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

NOL12 ERCC3 DDX31

5.00e-05195931080_DN
DrugAC1L1UI8

NUSAP1 NOL12

1.42e-044692CID000010107
DrugCaptopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A

NUSAP1 CEP57

2.13e-03179924585_DN
DrugLanatoside C [17575-22-3]; Down 200; 4uM; MCF7; HT_HG-U133A

NOL12 CEP57

2.18e-03181926048_DN
DrugICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A

CEP57 DDX31

2.23e-03183926925_DN
DrugEtoposide [33419-42-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A

NUSAP1 DDX31

2.28e-03185923241_DN
DrugSpiperone [749-02-0]; Down 200; 10.2uM; PC3; HT_HG-U133A

NRGN NOL12

2.30e-03186925777_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

NUSAP1 CEP57

2.33e-03187924302_DN
DrugStrophantine octahydrate [11018-89-6]; Down 200; 5.4uM; MCF7; HT_HG-U133A

NOL12 CEP57

2.33e-03187922656_DN
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

NRGN DDX31

2.33e-03187921631_DN
DrugRaloxifene hydrochloride [82640-04-8]; Down 200; 7.8uM; MCF7; HT_HG-U133A

NRGN DDX31

2.35e-03188923480_DN
DrugMonobenzone [103-16-2]; Down 200; 20uM; MCF7; HT_HG-U133A

NUSAP1 DDX31

2.37e-03189925312_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

CEP57 DDX31

2.37e-03189921045_DN
Drug17-AAG; Down 200; 1uM; PC3; HT_HG-U133A

NRGN NOL12

2.42e-03191921225_DN
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

NRGN NOL12

2.42e-03191926944_DN
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

NRGN MYBPC3

2.42e-03191924302_UP
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

NOL12 DDX31

2.42e-03191925204_DN
Drug2-propylpentanoic acid; Up 200; 1000uM; MCF7; HG-U133A

NRGN CEP57

2.45e-031929223_UP
Drugwortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA

NOL12 DDX31

2.47e-03193921081_DN
DrugLasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; HL60; HT_HG-U133A

DDX31 MYBPC3

2.47e-03193923021_UP
DrugGallamine triethiodide [65-29-2]; Down 200; 4.4uM; HL60; HG-U133A

NRGN ERCC3

2.47e-03193921375_DN
DrugQuercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A

NOL12 CEP57

2.47e-03193924846_DN
DrugFluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; HL60; HG-U133A

NRGN DDX31

2.47e-03193921577_UP
DrugEpivincamine [6835-99-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A

NRGN MYBPC3

2.50e-03194922775_UP
Druggeldanamycin; Down 200; 1uM; HL60; HT_HG-U133A

NOL12 DDX31

2.50e-03194921169_DN
DrugMoxalactam disodium salt [64953-12-4]; Down 200; 7uM; PC3; HT_HG-U133A

NOL12 DDX31

2.50e-03194924648_DN
DrugNeomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A

NRGN DDX31

2.50e-03194927221_DN
DrugBenfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A

NUSAP1 DDX31

2.50e-03194924312_DN
Drugradicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A

NOL12 DDX31

2.50e-03194925216_DN
DrugAcacetin [480-44-4]; Up 200; 14uM; MCF7; HT_HG-U133A

NOL12 MYBPC3

2.53e-03195923942_UP
DrugTranexamic acid [1197-18-8]; Down 200; 25.4uM; HL60; HG-U133A

NRGN NOL12

2.53e-03195921401_DN
DrugPerhexiline maleate [6724-53-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A

ERCC3 DDX31

2.53e-03195927441_DN
DrugCloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A

NRGN DDX31

2.53e-03195923408_DN
DrugNafronyl oxalate [3200-06-4]; Down 200; 8.4uM; HL60; HT_HG-U133A

NRGN NOL12

2.53e-03195921267_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

NRGN DDX31

2.53e-03195926927_DN
Drug2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A_EA

NOL12 DDX31

2.53e-03195921078_DN
DrugPentoxifylline [6493-05-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A

NOL12 MYBPC3

2.55e-03196926021_UP
DrugCotinine (-) [486-56-6]; Up 200; 22.6uM; PC3; HG-U133A

CEP57 DDX31

2.55e-03196921929_UP
DrugAllantoin [97-59-6]; Down 200; 25.2uM; MCF7; HT_HG-U133A

NRGN NOL12

2.55e-03196921678_DN
DrugIvermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A

NRGN NOL12

2.55e-03196922051_DN
DrugHexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; HL60; HG-U133A

ERCC3 MYBPC3

2.55e-03196921982_UP
DrugN-Acetyl-L-leucine [1188-21-2]; Down 200; 23uM; HL60; HT_HG-U133A

NRGN DDX31

2.55e-03196923085_DN
DrugAmethopterin (R,S) [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A

NOL12 MYBPC3

2.55e-03196925000_UP
DrugAmiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; PC3; HT_HG-U133A

NOL12 MYBPC3

2.55e-03196924000_UP
DrugLidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; HL60; HG-U133A

NRGN DDX31

2.55e-03196921999_UP
DrugThalidomide [50-35-1]; Down 200; 15.4uM; MCF7; HT_HG-U133A

CEP57 DDX31

2.55e-03196922258_DN
DrugCefadroxil [50370-12-2]; Up 200; 11uM; MCF7; HT_HG-U133A

NOL12 CEP57

2.55e-03196923259_UP
DrugMebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; PC3; HT_HG-U133A

NOL12 DDX31

2.55e-03196927147_DN
DrugLY294002; Down 200; 10uM; PC3; HT_HG-U133A

NOL12 DDX31

2.55e-03196925970_DN
Drugwortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A

NOL12 DDX31

2.55e-03196925240_DN
DrugDequalinium dichloride [522-51-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A

NOL12 DDX31

2.55e-03196922631_DN
DrugMerbromin [129-16-8]; Up 200; 5uM; MCF7; HT_HG-U133A

NOL12 MYBPC3

2.55e-03196924722_UP
DrugMeticrane [1084-65-7]; Up 200; 14.6uM; HL60; HT_HG-U133A

NOL12 DDX31

2.55e-03196921834_UP
DrugCalycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A

NRGN NOL12

2.55e-03196922764_DN
DrugMethylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; PC3; HT_HG-U133A

NOL12 MYBPC3

2.55e-03196923994_UP
Drugnifedipine; Up 200; 10uM; MCF7; HG-U133A

NRGN NOL12

2.58e-0319792335_UP
DrugSulmazole [73384-60-8]; Up 200; 14uM; PC3; HT_HG-U133A

NOL12 MYBPC3

2.58e-03197924009_UP
DrugAlprostadil [745-65-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A

NRGN MYBPC3

2.58e-03197927358_UP
DrugScoulerine [6451-73-6]; Down 200; 12.2uM; HL60; HG-U133A

NRGN NOL12

2.58e-03197921742_DN
DrugCeftazidime pentahydrate [78439-06-2]; Up 200; 6.2uM; HL60; HG-U133A

NOL12 MYBPC3

2.58e-03197921721_UP
Drugprochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A

NOL12 DDX31

2.58e-03197921215_DN
Drugdoxycycline; Up 200; 14.4uM; MCF7; HT_HG-U133A_EA

NRGN CEP57

2.58e-03197921113_UP
DrugStreptomycin sulfate [3810-74-0]; Up 200; 2.8uM; HL60; HG-U133A

NRGN NOL12

2.58e-03197921578_UP
DrugChlorhexidine [55-56-1]; Down 200; 8uM; HL60; HG-U133A

ERCC3 DDX31

2.58e-03197922025_DN
DrugLY 294002; Down 200; 0.1uM; PC3; HT_HG-U133A

NOL12 DDX31

2.58e-03197924440_DN
DrugHydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; HL60; HG-U133A

NRGN NOL12

2.58e-03197921436_DN
DrugLorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; PC3; HT_HG-U133A

NOL12 DDX31

2.58e-03197924658_DN
DrugMetaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A

NRGN DDX31

2.58e-03197922845_DN
Drug(+/-)-thalidomide; Up 200; 100uM; MCF7; HG-U133A

NRGN DDX31

2.60e-0319892266_UP
DrugAntipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; HL60; HG-U133A

ERCC3 DDX31

2.60e-03198921997_DN
DrugRanitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; HL60; HG-U133A

NRGN DDX31

2.60e-03198921404_DN
DrugBenzbromarone [3562-84-3]; Down 200; 9.4uM; HL60; HT_HG-U133A

NRGN DDX31

2.60e-03198921291_DN
DrugSulfinpyrazone [57-96-5]; Up 200; 9.8uM; HL60; HG-U133A

NRGN NOL12

2.60e-03198921574_UP
DrugXamoterol hemifumarate [73210-73-8]; Up 200; 5uM; MCF7; HT_HG-U133A

NRGN NOL12

2.60e-03198925363_UP
Drugcatechin; Down 200; 11uM; MCF7; HT_HG-U133A_EA

NOL12 DDX31

2.60e-03198921101_DN
DrugICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A

NOL12 DDX31

2.60e-03198921238_DN
DrugMianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A

NRGN NOL12

2.60e-03198922068_DN
DrugThalidomide [50-35-1]; Down 200; 15.4uM; HL60; HG-U133A

NRGN DDX31

2.60e-03198921411_DN
DiseaseAlzheimer's disease (is_marker_for)

NRGN ERCC3

2.61e-0325792DOID:10652 (is_marker_for)
Diseasecognitive function measurement, self reported educational attainment

CEP57 TNRC6A

4.91e-0335592EFO_0004784, EFO_0008354
Diseasealcohol consumption measurement

DDX31 MYBPC3 TNRC6A

5.16e-03124293EFO_0007878
Diseasecognitive function measurement

CEP57 MYBPC3 TNRC6A

7.72e-03143493EFO_0008354
Diseaseneuroticism measurement, cognitive function measurement

CEP57 TNRC6A

1.21e-0256692EFO_0007660, EFO_0008354
Diseaseserum albumin measurement

NOL12 MYBPC3

1.32e-0259292EFO_0004535
Diseaseattention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement

NRGN TNRC6A

2.33e-0280192EFO_0003888, EFO_0007052, MONDO_0002491

Protein segments in the cluster

PeptideGeneStartEntry
NKKDFMKLRPGEKRR

CEP57

461

Q86XR8
MGRNKKKKRDGDDRR

NOL12

1

Q9UGY1
MARKKIKSGERGRKG

NRGN

41

Q92686
ERKEKKAKVLGMRRG

NUSAP1

421

Q9BXS6
MGGEKRKSEKARLRK

DDX31

341

Q9H8H2
MGKRDRADRDKKKSR

ERCC3

1

P19447
MRNKSGGKKRRGSKR

PRSS35

191

Q8N3Z0
KKRRRERGMMKGGNK

TNRC6A

1181

Q8NDV7
RGMLKRLKGMRRDEK

MYBPC3

346

Q14896